See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

by Marc Lichtenfeld, Healthcare Expert Wednesday, November 11, 2009: Issue #1135 Investing in the biotech sector can be risky – no doubt about that. But you know what? There are a lot of ways to make money from biotech stocks, too. If you know what to look for, that is. Two obvious examples include: Picking the company [...]

(ASH) Investing in the Biotech Sector: Here’s An Easy Way to Profit from Biotech Stocks

Investing in the Biotech Sector: Here’s An Easy Way to Profit from Biotech Stocks by Marc Lichtenfeld, Healthcare Expert Wednesday, November 11, 2009: Issue #1135 Investing in the biotech sector can be risky – no doubt about that.[More...]

Cusick’s Corner Shorts seem to be on the defensive, especially after the G20 said that they will continue to provide Viagra, I mean stimulus (read summary below). This current rally is being scrutinized, checking if this is a short squeeze or if there is potentially more traction gaining in sectors that have ...

BloggingStocks: Analyst upgrades: Keefe Bruyette upgraded Blackstone Group (BX) to outperform from market perform following the company's Q3 results and maintains an $18.50 price target on shares. Baird upgraded Astec (ASTE) to outperform from neutral ... Read more

 

 

Symbol

Last/NAV

%Gain/Loss

ARIA

2.80

85.43%

ONTY

4.40

37.07%

SUPG

2.70

33.00%

GTXI

10.58

30.46%

FSYS

23.98

28.79%

SWC

6.39

26.04%

ONB

11.33

20.92%

SPPI

6.75

19.89%

PRXL

14.44

14.33%

UNG

12.90

5.91%

TOMO

2.78

5.30%

CLNE

8.94

3.83%

OSIR

12.70

1.36%

 

Data is based on the closing prices on Tuesday July 7 to Tuesday July 27, 2009.

 

 

Ariad Pharmaceuticals (Nasdaq: ARIA) shares jumped following a significant Phase 1 clinical trial announcement and in front of much anticipated interim phase 3 results for the company’s cancer drug, ridaforolimus.  An announcement is due any day.  ARIA will report quarterly earnings on Thursday, July 30 at 4:15 PM ET.  Investors can access the webcast here.

 

Spectrum Pharmaceuticals (Nasdaq: SPPI) continues its climb as investors anticipate the company’s two cancer drugs, Zevalin and Fusilev, will be approved on or before September 7 and October 8, 2009, respectively.

 

Old National Bank (NYSE: ONB) rose early this week on a positive quarterly earnings announcement.

 

 

Disclosure: Long ARIA and SPPI

Market Close Live for Wednesday 6/15/06 Topics covered today: 1) Market Wrap - Biggest rally for market in months 2) The small-cap indices lead the way with gains over 3% 3) Commodity indices form double-bottom 4) Stocks from the PFG RSI Buy Scan 5) Analysis of stock questions 6) Stocks and ETFs mentioned: KUB, FWLT, FLR, VOL, CTCI, CHDN, EN, MIKR, ARIA, XMSR, AZN, SIAL, UAPH, PSPT, MAN, SSI, SEIC, GRMN, PFG, CTRP, HOC, PHG, IMGC, BSC, CAT 7) "Market Close Live" IS NOW available as a "PODCAST" for those who have MP3 player. If you are interested in learning how to get "Market Close Live" on your MP3 player please email info@pennfinancialgroup.com. ***** TO GET YOUR STOCK/MARKET QUESTIONS ANSWERED YOU CAN EMAIL THEM TO: info@pennfinancialgroup.com